Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies May 31, 2019
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer May 30, 2019
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award May 29, 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S. May 20, 2019
Akrevia Therapeutics Appoints Distinguished Research Leaders to Scientific Advisory Board May 16, 2019
Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist May 16, 2019
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products May 15, 2019
FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions; Delivering 2023 Traceability By Leveraging Blockchain and Digital Recalls Across a Supply Network May 14, 2019
Baptist Health Partners with PatientPing, Enabling Real-Time Care Coordination Across Acute and Post-Acute Care Settings May 14, 2019